|
|
||||||||
INFECTION IN INJECTING DRUG USERS |

, M. M. BRETT
, B. I. DUERDEN
, N. K. FRY
, V. HALL
, V. HOPE, A. LIEFTUCHT, J. MCLAUCHLIN
, D. G. PITCHER
and A. WEILD
Communicable Disease Surveillance Centre, Public Health Laboratory Service, 61 Colindale Avenue, London NW9 5EQ, *Public Health Laboratory, Cardiff,
Respiratory and Systemic Infection Laboratory, Central Public Health Laboratory,
Anaerobe Reference Unit, Cardiff Public Health Laboratory and
Food Safety Microbiology Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London
Corresponding author: Dr J. A. Jones (e-mail: jjones{at}phls.org.uk).
Received 25 July 2002; accepted 8 August 2002.
Abstract
An outbreak of serious illness and death occurred in injecting drug users during 2000 in Scotland, Ireland and England. National and international collaboration was necessary for the investigation and management of this outbreak. In England and Wales active case-finding was initiated, coupled with standardised data collection and microbiological investigation of cases. Twenty-six definite or probable cases were identified in England between 1 April and 31 Aug. 2000; 17 of these occurred in the North. The overall case fatality was 50% (13/26). The principal apparent risk factor was a history of intramuscular or subcutaneous injection of heroin and the limited duration of the outbreak suggested that the problem might have been related to a particular supply of heroin. Clostridium novyi was isolated from two English cases. Taken in conjunction with contemporaneous microbiological and epidemiological results from Scottish and Irish cases, the probable aetiology for this outbreak was infection with C. novyi associated with both a particular supply of heroin and the method of preparation and injection used. A toolkit was distributed in Sept. 2000 to all Consultants for Communicable Disease Control in England and Wales to assist them with the ongoing surveillance, investigation and management of this condition. Lessons learned have been used to produce guidance for the investigation and management of outbreaks of unexplained serious illness of possible infective aetiology.
This article has been cited by other articles:
![]() |
E. M. Gardner, M. Kestler, A. Beieler, and R. W. Belknap Clostridium butyricum sepsis in an injection drug user with an indwelling central venous catheter J. Med. Microbiol., February 1, 2008; 57(2): 236 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heffron and I. R. Poxton A PCR approach to determine the distribution of toxin genes in closely related Clostridium species: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridium novyi {alpha} toxin J. Med. Microbiol., February 1, 2007; 56(2): 196 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Brett, G. Hallas, and O. Mpamugo Wound botulism in the UK and Ireland J. Med. Microbiol., June 1, 2004; 53(6): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Efstratiou, M. Emery, T. L. Lamagni, A. Tanna, M. Warner, and R. C. George Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales J. Med. Microbiol., June 1, 2003; 52(6): 525 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.S. BRAZIER, B.I. DUERDEN, V. HALL, J.E. SALMON, J. HOOD, M.M. BRETT, J. MCLAUCHLIN, and R.C. GEORGE Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team J. Med. Microbiol., November 1, 2002; 51(11): 985 - 989. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |